parkinson Flashcards

1
Q

Parkinsonism refers to the presence of…. (3)

A

rest tremors
rigidity
bradykinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how to treat Parkinson in early symptomatic stage without complications

A

physiotherapy and exercise regime
healthy and balanced diet
knowledge on disease
social support

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

classes of oral medications in antiparkinson

A

anticholinergic agents
MAO-B/COM-T inhibitors
dopamine agonists
levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 2 levodopa preparations

A

levodopa + benserazide: madopar
levodopa + carbidopa: sinemet
available as a regular form or long acting form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

side effects of levodopa

A

short term: nausea, vomiting postural hypotension

long term: motor fluctuations and dyskinesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is an example of anticholinergics

A

trihexyphenidul (Artane) 2-15mg.day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

advantages of anticholinergics

A

effective in controlling tremor

peripherally acting agents may be useful in treating sialorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SE of anticholinergics

A

dry mouth, sedation, constipation, urinary retention, delirium, confusion, hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how should anticholinergic agents be used

A

symptomatic mono therapy or as an adjunct to levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

example of MAO-B inhibitors (1)

A

selegiline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

when is the MAO-B inhibitors used

A

mild antiparkinson activity

symptomatic monotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how does MAO=B wrk

A

inhibit enzyme monoamine oxidase B, interferes with breakdown of dopamine
may delay the mitral brain cell degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SE of MAO-B

A

heartburn, loss of appetite, nausea, constipation, dizziness, anxiety, headache, palpitation, insomnia, confusion, nightmares, visual hallucination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name 2 COMT inhibitors

A

entacopone

tolcapone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MOA of COMT

A

blocks an enzyme that converts levodopa into an inactive form
more levodopa available to enter the brain
only effective when used with levodopa
increases duration of each dose of levodopa, beneficial in treating ‘wearing off’ response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

side effects of COMT

A
increased abnormal movements (dyskinesias) 
liver dysfunction (tolcapone) 
nausea, diarrhoea 
urinary discolouration
visual hallucinations actions 
daytime drowsiness, sleep disturbances
17
Q

name 5 dopamine agonists

A

bromocriptine, pergolide, piribedil, ropinirole, pramipexole

18
Q

MOA of dopamine agonists

A

act directly on dopamine receptors in the brain to reduce the symptoms of PD

19
Q

usage of dopamine agonists

A

prevent or delay onset of motor complications

20
Q

SE of dopamine agonists

A

fibrosis, pedal edema, somnolence with ropinirole, pramipexole
arrhythmia
pergolide: restrictive valvular heart disease

21
Q

When to use dopamine agonists

A

symptomatic mono therapy
adjunct to levodopa in the treatment of Parkinson’s disease
younger Parkinson’s disease patients, therapy should commence first with dopamine agonists rather than levodopa

22
Q

what is amantadine

A

antiviral agents, accidentally discovered to have mild antiparkinsonian effect
given mono therapy or adjunct to levodopa

23
Q

amantadine MOA

A

enhance release of stored dopamine
inhibit presynaptic uptake of catecholamine
dopamine receptor agonist
NMDA receptor antagonist (anti-glutamate)
antidyskinetic

24
Q

when to use amantadine

A

reduce dyskinesia in patients with Parkinson’s disease who have motor fluctuations

25
Q

SE of amantadine

A

limits its use in advanced disease
cognitive impairment (inability to concentrate), hallucination, insomnia, night ares, lived reticular
mottled reticulated discolouration of limbs